Catherine Wood's CDNA Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 2.14 M shares of CareDx, Inc. (CDNA) worth $40.25 M, representing 0.27% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in CDNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 2.2 M shares. Largest reduction occurred in Q3 2024, reducing 2.71 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's CareDx (CDNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly CareDx (CDNA) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -34,222 | Reduce 1.58% | 2.14 M | $18.84 |
| Q3 2025 | +70,468 | Add 3.36% | 2.17 M | $14.54 |
| Q2 2025 | -247,225 | Reduce 10.53% | 2.1 M | $19.54 |
| Q1 2025 | -61,718 | Reduce 2.56% | 2.35 M | $17.75 |
| Q4 2024 | -579,497 | Reduce 19.39% | 2.41 M | $21.41 |
| Q3 2024 | -2.71 M | Reduce 47.59% | 2.99 M | $31.23 |
| Q2 2024 | -161,695 | Reduce 2.76% | 5.7 M | $15.53 |
| Q1 2024 | -1.33 M | Reduce 18.50% | 5.86 M | $10.59 |
| Q4 2023 | +515,399 | Add 7.72% | 7.19 M | $12.00 |
| Q3 2023 | +40,973 | Add 0.62% | 6.68 M | $7.00 |
| Q2 2023 | -161,089 | Reduce 2.37% | 6.64 M | $8.50 |
| Q1 2023 | +611,257 | Add 9.88% | 6.8 M | $9.14 |
| Q4 2022 | +401,062 | Add 6.93% | 6.19 M | $11.41 |
| Q3 2022 | +1.79 M | Add 44.84% | 5.79 M | $17.02 |
| Q2 2022 | +484,216 | Add 13.79% | 4 M | $25.15 |
| Q1 2022 | -127,540 | Reduce 3.51% | 3.51 M | $36.99 |
| Q4 2021 | +228,621 | Add 6.70% | 3.64 M | $45.48 |
| Q3 2021 | -1.15 M | Reduce 25.28% | 3.41 M | $63.37 |
| Q2 2021 | +103,286 | Add 2.32% | 4.56 M | $91.52 |
| Q1 2021 | +398,502 | Add 9.81% | 4.46 M | $68.09 |
| Q4 2020 | +2.2 M | Add 118.50% | 4.06 M | $72.45 |
| Q3 2020 | +583,725 | Add 45.76% | 1.86 M | $37.94 |
| Q2 2020 | +487,358 | Add 61.84% | 1.28 M | $35.43 |
| Q1 2020 | +222,706 | Add 39.39% | 788,144 | $21.83 |
| Q4 2019 | +248,138 | Add 78.20% | 565,438 | $21.57 |
| Q3 2019 | +189,692 | Add 148.65% | 317,300 | $22.61 |
| Q2 2019 | +127,608 | New Buy | 127,608 | $35.99 |
Catherine Wood's CareDx Investment FAQs
Catherine Wood first purchased CareDx, Inc. (CDNA) in Q2 2019, acquiring 127,608 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held CareDx, Inc. (CDNA) for 27 quarters since Q2 2019.
Catherine Wood's largest addition to CareDx, Inc. (CDNA) was in Q4 2020, adding 4,062,322 shares worth $294.32 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 2,136,403 shares of CareDx, Inc. (CDNA), valued at approximately $40.25 M.
As of the Q4 2025 filing, CareDx, Inc. (CDNA) represents approximately 0.27% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in CareDx, Inc. (CDNA) was 7,194,722 shares, as reported at the end of Q4 2023.